Jerry Salyers

13 papers; 13 titles; 4 coauthors.

Back to authors

Conference ×	Year ×	Title ×	Co-authors	Extras	Pages
PharmaSUG	2019	Considerations and Updates in the Use of Timing Variables in Submitting SDTM-Compliant Datasets		source	9
PharmaSUG	2018	SDTM EX and EC: Considerations When Submitting Exposure Data	Kristin Kelly	source	8
PHUSE EU	2017	Considerations and Conventions in the Submission of the SDTM Tumor and Response Domain	Fred Wood	source presentation source	7
PharmaSUG	2017	Considerations and Conventions in the Submission of the SDTMIG Tumor and Response Domains	Fred Wood	source	7
PharmaSUG	2016	Considerations and Conventions within the Therapeutic Area User Guides (TAUGs)	Kristin Kelly, Fred Wood	source	8
PharmaSUG	2016	SDTM Trial Summary Domain: Putting Together the TS Puzzle	Kristin Kelly, Fred Wood	source	13
PharmaSUG	2015	Considerations in Submitting Non-Standard Variables: Supplemental Qualifiers, Findings About, or a Custom Findings Domain	Richard Lewis, Fred Wood	source	6
PharmaSUG	2015	SDTM TE, TA, and SE Domains: Demystifying the Development of SE	Kristin Kelly, Fred Wood	source	6
PHUSE EU	2014	Considerations in Creating Transparent SDTM-Based Datasets	Richard Lewis	source presentation source	8
PharmaSUG	2014	Considerations in Creating SDTM Trial Design Datasets	Richard Lewis, Kimberly Minkalis, Fred Wood	source	9
PharmaSUG	2014	Considerations in the Submission of Exposure Data in SDTM-Based Datasets	Fred Wood, Richard Lewis, Kristin Kelly	source	6
PharmaSUG	2013	Considerations in the Use of Timing Variables in Submitting SDTM-Compliant Datasets	Richard Lewis, Fred Wood	source	6
PharmaSUG	2012	Considerations in the Submission of Exposure Data in an SDTM-Compliant Format	Fred Wood, Richard Lewis	source	4

Back to authors